460 related articles for article (PubMed ID: 16867161)
1. Dynamic T-lymphocyte chemokine receptor expression induced by interferon-beta therapy in multiple sclerosis.
Krakauer M; Sorensen PS; Khademi M; Olsson T; Sellebjerg F
Scand J Immunol; 2006 Aug; 64(2):155-63. PubMed ID: 16867161
[TBL] [Abstract][Full Text] [Related]
2. Increased IL-10 mRNA and IL-23 mRNA expression in multiple sclerosis: interferon-beta treatment increases IL-10 mRNA expression while reducing IL-23 mRNA expression.
Krakauer M; Sorensen P; Khademi M; Olsson T; Sellebjerg F
Mult Scler; 2008 Jun; 14(5):622-30. PubMed ID: 18424480
[TBL] [Abstract][Full Text] [Related]
3. Multiple sclerosis and optic neuritis: CCR5 and CXCR3 expressing T cells are augmented in blood and cerebrospinal fluid.
Teleshova N; Pashenkov M; Huang YM; Söderström M; Kivisäkk P; Kostulas V; Haglund M; Link H
J Neurol; 2002 Jun; 249(6):723-9. PubMed ID: 12111306
[TBL] [Abstract][Full Text] [Related]
4. Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.
Mitsdoerffer M; Schreiner B; Kieseier BC; Neuhaus O; Dichgans J; Hartung HP; Weller M; Wiendl H
J Neuroimmunol; 2005 Feb; 159(1-2):155-64. PubMed ID: 15652415
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of chemokine expression by interferon beta therapy in patients with multiple sclerosis.
Cepok S; Schreiber H; Hoffmann S; Zhou D; Neuhaus O; von Geldern G; Hochgesand S; Nessler S; Rothhammer V; Lang M; Hartung HP; Hemmer B
Arch Neurol; 2009 Oct; 66(10):1216-23. PubMed ID: 19667211
[TBL] [Abstract][Full Text] [Related]
6. Time-dependent cytokine deviation toward the Th2 side in Japanese multiple sclerosis patients with interferon beta-1b.
Ochi H; Feng-Jun M; Osoegawa M; Minohara M; Murai H; Taniwaki T; Kira J
J Neurol Sci; 2004 Jul; 222(1-2):65-73. PubMed ID: 15240198
[TBL] [Abstract][Full Text] [Related]
7. Expansion of CD4+CD28- T cells producing high levels of interferon-{gamma} in peripheral blood of patients with multiple sclerosis.
Miyazaki Y; Iwabuchi K; Kikuchi S; Fukazawa T; Niino M; Hirotani M; Sasaki H; Onoé K
Mult Scler; 2008 Sep; 14(8):1044-55. PubMed ID: 18573819
[TBL] [Abstract][Full Text] [Related]
8. Differential intracellular expression of CCR5 and chemokines in multiple sclerosis subtypes.
Jalonen TO; Pulkkinen K; Ukkonen M; Saarela M; Elovaara I
J Neurol; 2002 May; 249(5):576-83. PubMed ID: 12021948
[TBL] [Abstract][Full Text] [Related]
9. Effect of IFN-beta therapy on the frequency and function of CD4(+)CD25(+) regulatory T cells and Foxp3 gene expression in relapsing-remitting multiple sclerosis (RRMS): a preliminary study.
Namdar A; Nikbin B; Ghabaee M; Bayati A; Izad M
J Neuroimmunol; 2010 Jan; 218(1-2):120-4. PubMed ID: 19932513
[TBL] [Abstract][Full Text] [Related]
10. Interferon-beta up-regulates the expression of co-stimulatory molecules CD80, CD86 and CD40 on monocytes: significance for treatment of multiple sclerosis.
Marckmann S; Wiesemann E; Hilse R; Trebst C; Stangel M; Windhagen A
Clin Exp Immunol; 2004 Dec; 138(3):499-506. PubMed ID: 15544628
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic and functional characterisation of CCR7+ and CCR7- CD4+ memory T cells homing to the joints in juvenile idiopathic arthritis.
Gattorno M; Prigione I; Morandi F; Gregorio A; Chiesa S; Ferlito F; Favre A; Uccelli A; Gambini C; Martini A; Pistoia V
Arthritis Res Ther; 2005; 7(2):R256-67. PubMed ID: 15743472
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of CCR4 expression in adult T-cell leukemia/lymphoma: its close association with skin involvement and unfavorable outcome.
Ishida T; Utsunomiya A; Iida S; Inagaki H; Takatsuka Y; Kusumoto S; Takeuchi G; Shimizu S; Ito M; Komatsu H; Wakita A; Eimoto T; Matsushima K; Ueda R
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3625-34. PubMed ID: 14506150
[TBL] [Abstract][Full Text] [Related]
13. The chemokine and chemokine receptor profile of infiltrating cells in the wall of arteries with cardiac allograft vasculopathy is indicative of a memory T-helper 1 response.
van Loosdregt J; van Oosterhout MF; Bruggink AH; van Wichen DF; van Kuik J; de Koning E; Baan CC; de Jonge N; Gmelig-Meyling FH; de Weger RA
Circulation; 2006 Oct; 114(15):1599-607. PubMed ID: 17015796
[TBL] [Abstract][Full Text] [Related]
14. Reduced CC chemokine receptor (CCR) 1 and CCR5 surface expression on peripheral blood T lymphocytes from patients with chronic hepatitis C infection.
Lichterfeld M; Leifeld L; Nischalke HD; Rockstroh JK; Hess L; Sauerbruch T; Spengler U
J Infect Dis; 2002 Jun; 185(12):1803-7. PubMed ID: 12085329
[TBL] [Abstract][Full Text] [Related]
15. CCR4 memory CD4+ T lymphocytes are increased in peripheral blood and lesional skin from patients with atopic dermatitis.
Nakatani T; Kaburagi Y; Shimada Y; Inaoki M; Takehara K; Mukaida N; Sato S
J Allergy Clin Immunol; 2001 Feb; 107(2):353-8. PubMed ID: 11174204
[TBL] [Abstract][Full Text] [Related]
16. Association of Th1/Th2-related chemokine receptors in peripheral T cells with disease activity in patients with multiple sclerosis and neuromyelitis optica.
Shimizu Y; Ota K; Kubo S; Kabasawa C; Kobayashi M; Ohashi T; Uchiyama S
Eur Neurol; 2011; 66(2):91-7. PubMed ID: 21846991
[TBL] [Abstract][Full Text] [Related]
17. Expression and functional activity of chemokine receptors in glatiramer acetate-specific T cells isolated from multiple sclerosis patient receiving the drug glatiramer acetate.
Høglund RA; Hestvik AL; Holmøy T; Maghazachi AA
Hum Immunol; 2011 Feb; 72(2):124-34. PubMed ID: 20977917
[TBL] [Abstract][Full Text] [Related]
18. Production of thymus and activation-regulated chemokine and macrophage-derived chemokine by CCR4+ adult T-cell leukemia cells.
Shimauchi T; Imai S; Hino R; Tokura Y
Clin Cancer Res; 2005 Mar; 11(6):2427-35. PubMed ID: 15788694
[TBL] [Abstract][Full Text] [Related]
19. Expression of TH1/TH2-related chemokine receptors on peripheral T cells and correlation with clinical disease activity in patients with multiple sclerosis.
Nakajima H; Fukuda K; Doi Y; Sugino M; Kimura F; Hanafusa T; Ikemoto T; Shimizu A
Eur Neurol; 2004; 52(3):162-8. PubMed ID: 15528917
[TBL] [Abstract][Full Text] [Related]
20. Periplocoside E inhibits experimental allergic encephalomyelitis by suppressing interleukin 12-dependent CCR5 expression and interferon-gamma-dependent CXCR3 expression in T lymphocytes.
Zhu YN; Zhong XG; Feng JQ; Yang YF; Fu YF; Ni J; Liu QF; Tang W; Zhao WM; Zuo JP
J Pharmacol Exp Ther; 2006 Sep; 318(3):1153-62. PubMed ID: 16751252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
